$2.07
Cellectar Biosciences is a biotechnology business based in the US. Cellectar Biosciences shares (CLRB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.09 – an increase of 0.48% over the previous week. Cellectar Biosciences employs 20 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Cellectar Biosciences stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Cellectar Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CLRB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cellectar Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cellectar Biosciences stock price (NASDAQ: CLRB)
Use our graph to track the performance of CLRB stocks over time.Cellectar Biosciences shares at a glance
Latest market close | $2.09 |
---|---|
52-week range | $1.82 - $4.45 |
50-day moving average | $2.08 |
200-day moving average | $2.95 |
Wall St. target price | $12.60 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-3.09 |
Is it a good time to buy Cellectar Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cellectar Biosciences price performance over time
Historical closes compared with the close of $2.09 from 2024-10-18
1 week (2024-10-14) | 0.48% |
---|---|
1 month (2024-09-20) | 0.97% |
3 months (2024-07-19) | -17.06% |
6 months (2024-04-19) | -31.02% |
1 year (2023-10-20) | -20.53% |
---|---|
2 years (2022-10-21) | 14.84% |
3 years (2021-10-21) | 127.17% |
5 years (2019-10-21) | 33.97% |
Cellectar Biosciences financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -91.47% |
Return on equity TTM | -304.38% |
Profit margin | 0% |
Book value | $0.27 |
Market Capitalization | $76.4 million |
TTM: trailing 12 months
Cellectar Biosciences share dividends
We're not expecting Cellectar Biosciences to pay a dividend over the next 12 months.
Have Cellectar Biosciences's shares ever split?
Cellectar Biosciences's shares were split on a 1:10 basis on 21 July 2022 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellectar Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Cellectar Biosciences shares which in turn could have impacted Cellectar Biosciences's share price.
Cellectar Biosciences share price volatility
Over the last 12 months, Cellectar Biosciences's shares have ranged in value from as little as $1.82 up to $4.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellectar Biosciences's is 0.992. This would suggest that Cellectar Biosciences's shares are less volatile than average (for this exchange).
Cellectar Biosciences overview
Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey. .
Frequently asked questions
nullWhat percentage of Cellectar Biosciences is owned by insiders or institutions?
Currently 3.213% of Cellectar Biosciences shares are held by insiders and 35.063% by institutions. How many people work for Cellectar Biosciences?
Latest data suggests 20 work at Cellectar Biosciences. When does the fiscal year end for Cellectar Biosciences?
Cellectar Biosciences's fiscal year ends in December. Where is Cellectar Biosciences based?
Cellectar Biosciences's address is: 100 Campus Drive, Florham Park, NJ, United States, 07932 What is Cellectar Biosciences's ISIN number?
Cellectar Biosciences's international securities identification number is: US15117F5008 What is Cellectar Biosciences's CUSIP number?
Cellectar Biosciences's Committee on Uniform Securities Identification Procedures number is: 67000M100
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question